ANG Lifesciences India Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated loss before tax of ₹374.57 lakhs for the quarter. Additionally, the Board of Directors has approved the appointment of Mrs. Preeti Sarin as an Additional Independent Director for a term of five years, effective from November 14, 2026.
Financial Highlights for Q2 FY27
ANG Lifesciences India Limited has released its unaudited financial results for the quarter and six months ended September 30, 2026. For the quarter, the company reported total revenue of ₹2,020.93 lakhs. The consolidated loss before tax for the quarter stood at ₹374.57 lakhs, compared to a loss of ₹557.95 lakhs in the previous quarter. The total comprehensive loss for the quarter was ₹207.07 lakhs.
For the six-month period ended September 30, 2026, the consolidated total revenue was ₹3,561.46 lakhs. The consolidated loss before tax for the six months was ₹932.52 lakhs, and the total comprehensive loss was ₹629.72 lakhs.
Standalone Financials
On a standalone basis, the company reported revenue from operations of ₹1,857.59 lakhs for the quarter ended September 30, 2026. The standalone loss before tax for the quarter was ₹339.14 lakhs, with a total comprehensive loss of ₹266.05 lakhs.
For the six-month period ended September 30, 2026, standalone revenue from operations stood at ₹3,253.38 lakhs. The standalone loss before tax was ₹790.26 lakhs, and the total comprehensive loss was ₹607.82 lakhs.
Board Appointment
The Board of Directors has approved the appointment of Mrs. Preeti Sarin as an Additional Independent Director. She will hold office for a period of five consecutive years, from November 14, 2026, to November 13, 2031, subject to shareholder approval. Mrs. Sarin brings over 10 years of professional experience in business administration and management. The company confirmed that she meets the independence criteria and is not debarred from holding a director’s position.
Emphasis of Matter
The Independent Auditor’s Review Report highlights certain undisputed statutory dues that have not been deposited by the company within the prescribed due dates. These include dues related to Employees’ State Insurance (ESI), Employees’ Provident Fund (EPF), and Tax Deducted at Source (TDS). Some of these dues have remained unpaid for over six months. Additionally, the report mentions pending disputed demands from the Income Tax Department and defaults in repayment of interest and/or instalments for certain borrowings from HDFC Bank.
The auditors also noted that the company was unable to provide the stock statement as of September 30, 2026, which restricted the verification of Drawing Power against Cash Credit facilities. Similarly, certain statements for current accounts maintained before the NCLT takeover could not be provided, limiting the scope of the review.
Source: BSE
